September 29th 2023
Treatment with diazepam nasal spray resulted in a statistically significant change in time between seizure clusters, potentially reflecting a beneficial effect of intermittent rescue therapy.
September 27th 2023
September 21st 2023
Pediatric Patients With FCD, LEAT Exhibit No Significant Changes in IQ, QOL After Surgery
April 22nd 2023The systematic review and meta-analysis showed no correlation between epilepsy surgery and intelligence quotient (IQ) or quality of life (QOL) among younger patients with facial cortical dysplasia (FCD) and long-term epilepsy-associated tumors (LEAT).
Read More
Elevated IL-6 Concentrations Seen in Patients With High GADA Titers
April 18th 2023The findings from this single-center cross-sectional study, say the researchers, suggest that IL-6 signaling may be a promising target for the treatment of patients with glutamic acid decarboxylase (GADA)–induced autoimmune epilepsy.
Read More
Association With Autoimmune Diseases Differs Between Epilepsy Types
April 12th 2023The researchers of a single-center study found that the relationships between epilepsy and autoimmune diseases may be a result of the different etiopathogenetic mechanisms that underly seizure development in each syndrome.
Read More
Pregnant Women With Epilepsy Experience Worse Perinatal Outcomes
March 15th 2023Findings of a meta-analysis showed that women with epilepsy were at increased odds of miscarriage, stillbirth, and maternal death, and risk of poor perinatal outcomes increased with greater use of antiseizure medication.
Read More
High Incidence of Medication Errors Following Hospital Discharge Shown in Pediatric Epilepsy
March 3rd 2023Incidence of medication problems and their harm potential following hospital discharge among pediatric patients with epilepsy were not significantly different for individuals who received discharge medication education and those who did not.
Read More
Midazolam Nasal Spray Effective in Managing Seizure Clusters in Epilepsy
March 1st 2023Patients treated with 5-mg midazolam nasal spray were more likely than those given placebo to remain seizure free for 6 hours after treatment or have their seizure terminated within 10 minutes, with no recurrence seen from 10 minutes to 6 hours after the treatment.
Read More
Telementoring Program Linked With Improvement in Epilepsy Care Among School Nurses
February 22nd 2023School nurses reported improved knowledge and confidence in the care of students with seizures after undergoing the Project ECHO (Extension for Community Healthcare Outcomes) telementoring program for epilepsy.
Read More
Long-term Antidepressant Drug Use Linked With Risk of Epilepsy
February 11th 2023Individuals exposed to antidepressant drugs for longer than 365 days had an increased risk of epilepsy, particularly those given escitalopram, venlafaxine, and mirtazapine, according to a recent study conducted in Taiwan.
Read More
Dietary Therapies Show Short-term Effectiveness for Childhood Drug-Resistant Epilepsy
February 6th 2023The modified Atkins diet exhibited superior tolerability and effectiveness in reducing seizure frequency compared with other dietary therapies in the management of childhood drug-resistant epilepsy.
Read More
Epilepsy Incidence, Prevalence Greater in More Deprived UK Regions
February 1st 2023Significant geographical variation was found regarding the prevalence and incidence of epilepsy in United Kingdom primary care data between 2013 and 2018, suggesting a potential relationship between the disease and deprivation.
Read More
Valproate Exhibits Both Hypnotic, Antiepileptic Properties During Sleep
January 21st 2023In an animal study, researchers found that valproate, a common epilepsy drug, possessed hypnotic and antiepileptic properties during sleep, suggesting that the drug could help improve sleep quality for patients with nocturnal epilepsy.
Read More
Newer Drugs for Epilepsy Less Likely to Be Prescribed to Black, Latino Patients on Medicaid
January 11th 2023Patients with epilepsy on Medicaid insurance of Black, Latino, and Native Hawaiian and Other Pacific Island ethnicity were associated with lower odds of being on newer, second- and third-generation, antiseizure medications compared with White individuals.
Read More
In Pediatric Epilepsy, Links Found Between Parental Factors, Emotional and Behavioral Issues
January 10th 2023A study showed 18.3% of adolescents with epilepsy (AWE) had at least 1 emotional or behavioral problem, and 24.9% of parents felt others had stigma towards their children with epilepsy.
Read More
Developing a Framework to Address Health Inequities in Epilepsy
January 6th 2023A review explored the connection between 4 domains (structural, sociocultural, health care, and physiological) contributing to the persistence of inequities in epilepsy risk and outcomes in the United States, as well as key areas of intervention to promote health equity.
Read More
Raising the Overall Awareness for Infantile Spasms, Early Recognition of Pre-Epilepsy Diagnosis
December 22nd 2022Martina Bebin, MD, MPA, professor of neurology, University of Alabama at Birmingham Epilepsy Center, discussed Infantile Spasms Awareness Week, the strides made within the field, and the emphasis on early and accurate diagnosis.
Read More
Telemedicine Care Quality, Social Vulnerability Index Barriers Measured for Patients With Epilepsy
December 12th 2022Abstracts from the American Epilepsy Society annual meeting show that telemedicine is capable of meeting the needs of patients with epilepsy, and that the patient portal accessibility for patients experiencing high social vulnerability index needs further research.
Read More
Two Pediatric Tertiary Care Centers Evaluate Efficacy of CBD on Refractory, Intractable Epilepsy
December 9th 2022Abstracts from the American Epilepsy Society (AES) display potential benefits of cannabidiol (CBD) on pediatric patients with epilepsy in tertiary care centers and highlight areas where further research is needed.
Read More